Skip to content Skip to footer

Unraveling the Trajectory of the Endoscope Reprocessing Market: A Comprehensive Analysis

The endoscope reprocessing industry is witnessing an upswing due to rising acceptance of sophisticated medical procedures. In 2022, the market size was valued at $2,655.6 million and it’s projected to reach an impressive $7,374.5 million by 2032, growing at a compound annual growth rate (CAGR) of 10.9%. Various factors are contributing to this remarkable growth, with Ambulatory Surgical Center (ASC) based endoscopic procedures being a significant influencer due to their cost-effectiveness and reduced post-operative complications. Rising trends in outpatient surgeries, early cancer diagnosis, and minimally invasive surgeries have accelerated the demand for endoscopy devices, reinforcing the growth of the endoscope reprocessing market.

These devices are quite advantageous to a variety of medical and diagnostic centers, research centers, and specialty clinics. Technological advancements in endoscopes, visualization systems, and associated components further fuel demand for these devices. The endoscope devices market is being bolstered by advancements in portability, High Definition imaging, and microendoscopy, which facilitate accurate diagnoses. With an increased demand for these diagnostic procedures, the potential risk of infections due to improper sterilization has drawn public attention.

Despite infections being a known complication of endoscopy procedures, the persistent risk of residual bacteria in sterilized endoscopes contributing to patient infection necessitates the demand for reliable reprocessing products, and in turn, continues to expand the market. The endoscope reprocessing market can be segmented based on type, end-user, and region. Automated endoscope reprocessors, capable of exterminating microorganisms on reusable endoscopes through disinfectant exposure, are primarily marketed to hospitals due to the high risk of surgical infections. Global trends show the endoscope reprocessing market growing at a CAGR of 10.9% by 2032.

Hospital investment in endoscopy instrumentation and the adoption of automated endoscope reprocessors for proficient infection control drives this growth. Using Automated Endoscope Reprocessors diminishes personnel exposure to potentially harmful chemical germicides. The prominence of gastrointestinal and colorectal diseases propels North America, especially the United States, to hold the largest market share for endoscope processing equipment. Key players in the endoscope reprocessing industry consist of Advanced Sterilization Products (of Johnson & Johnson), Boston Scientific Corporation, Cantel Medical, and others. Major trends and insights highlight the expansion of sterilization monitoring by Advanced Sterilization Products with new steam monitoring products for greater sterilization efficiency. Cantel emphasized the need to minimize endoscope damage, reduce repair costs, and lower infection risks.


Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]